ImmunoGen, Inc. IMGN announced today that it has priced an underwritten public offering of 7,000,000 shares of its common stock at a price to the public of $12.00 per share. Gross proceeds are expected to be approximately $84.0 million, before deducting the underwriting discounts and commissions and offering expenses payable by ImmunoGen.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in